ArticleJHEP reports : innovation in hepatology2025
Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s).
Mattias Mandorfer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.